Slingshot members are tracking this event:

Phase 3 data of ONIVYDE for first line pancreatic due 1H 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
MACK Community voting in process
IPSEY Community voting in process

Additional Information

Additional Relevant Details
  • Results from the Phase 2 clinical study of ONIVYDE in previously untreated front-line metastatic pancreatic cancer in the first half of 2017;
Additional Relevant Details Update on 9 Jan 2017: Ipsen acquires oncology pipeline (including Onivyde) from Merrimack
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 2 Data, Onivyde, First Line Pancreatic